title: Elevation of high density lipoprotein cholesterol (cHDL) and reduction of the total cholesterol/cHDL index in the treatment of hyperlipoproteinaemias IIb and IV with bezafibrate.
abstract: A study was carried out in 21 patients with Type IIb or Type IV hyperlipoproteinaemia to evaluate the effect of treatment with 600 mg bezafibrate per day over a period of 3 months. The results of the lipid parameters studied showed that there were significant reductions after 1 and 3-months' treatment, respectively, of 19% and 16% total cholesterol, 55% and 57% triglycerides, 19% and 15% calculated cLDL, and 55% and 58% calculated cVLDL. Over the same times, there was a significant increase in cHDL of 35% and 41%, respectively. The cT/cHDL index decreased significantly from a mean basal value of 7.81 +/- 1.44 to 4.76 +/- 0.96 after 1 month and to 4.75 +/- 0.90 after 3 months, corresponding to a 39% reduction in both instances. This index was reduced to 5.0 or less in 76% of the patients. At the end of the trial there was normalization of hyperlipoproteinaemia in 17 (81%) of the 21 patients. Tolerance of bezafibrate was satisfactory. Only 2 patients suffered mild abdominal pain, which disappeared within a few days. One patient presented slight, transitory neutropenia at the end of the 3 months of treatment.
mesh_terms: D000328:Adult; D000368:Aged; D001629:Bezafibrate; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D008875:Middle Aged; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D014280:Triglycerides; D002995:Clofibric Acid; D002784:Cholesterol; D002994:Clofibrate; D001629:Bezafibrate